{"id":781374,"date":"2023-08-31T10:20:40","date_gmt":"2023-08-31T14:20:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/"},"modified":"2023-08-31T10:20:40","modified_gmt":"2023-08-31T14:20:40","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/","title":{"rendered":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BALA CYNWYD, Pa., Aug.  31, 2023  (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pbyEu01ZITfURmYrCznf3vjCT42Vc_BTKbXAWqf_m4CC1ZZrghQG1RFFFgFQGck2IQnD-1KSnICfWcatZI5UvSe_WKef5iQ3yyPNKA1pmXXjkZPVPkhX9M45YmTdNX5R\" rel=\"nofollow noopener\" target=\"_blank\">jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Rg1z9HzLvrSxnBG4jXHLppCW4Eid6GoOw0huFIxF2ZNMN2bUUhHXDgpNEt4S3-q_divlL65PmMn9q0H2gnSP7FYfX1q-K_yPChYkEAgGPEEKHoxaBBrGrw0EhernGEMz\" rel=\"nofollow noopener\" target=\"_blank\">mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n<p>\n        <strong>Acer Therapeutics Inc. (Nasdaq &#8211; ACER) <\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Agreement, Acer will be acquired by Zevra Therapeutics, Inc. (\u201cZevra\u201d) (Nasdaq &#8211; ZVRA). At closing, Zevra would issue 0.121 of a share of Zevra\u2019s common stock in respect of each share of Acer\u2019s common stock. In addition, Acer stockholders of record as of immediately prior to the effective time of the merger would receive non-transferable CVRs entitling the holders to receive up to $34 million in cash upon the achievement of certain commercial milestones for OLPRUVA, and up to an additional $42 million in cash upon the achievement of certain regulatory milestones for OLPRUVA and EDSIVO. The investigation concerns whether the Acer Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Zevra is paying fair value to shareholders of the Company.<\/p>\n<p>Additional information can be found at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RH8CixSm5isNw_-Z0yODtjTvNd17nuE8ECXLpsfTdY2HlHG7MRHhToREJqnnVoiQLAOg_R08xSj-lPyrdXevQRGjrexg638wWZhr1VFwxaDBp-7P-iS7amlWGLRtBEq0Yn2Uii9abfw6tJtQzcm7qR7oECu5lG0f2iBYp_GdHg5E04p59fa1yn_zgDxywjNd6_AsgKikuBF5I4c6k4qZbp2a98FXhLYvhgtED_sxVEA=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/acer-therapeutics-inc-nasdaq-acer-2\/<\/a>.<\/p>\n<p>\n        <strong>Sovos Brands, Inc. (Nasdaq &#8211; SOVO)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Sovos will be acquired by Campbell Soup Company (NYSE &#8211; CPB). Each share of Sovos common stock will be entitled to receive $23.00 per share in cash, representing a total enterprise value of approximately $2.7 billion. The investigation concerns whether the Sovos Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Campbell Soup is paying fair value to shareholders of the Company.<\/p>\n<p align=\"justify\">Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RH8CixSm5isNw_-Z0yODtjTvNd17nuE8ECXLpsfTdY0osZuIu9djEGKK26PSAie7gaGC_QXdYXUPXQXJ14Nn4ICtq4dBLBi62rBmc1Oh1dbH4z-Ep814bk1cjjKVvr_DWNXRmMDtPD00Bx4OJQrwV3yx0iUYxKD8D__RFvSB1a0t8pVgkUW94RkKxTn61odySprvH-yG3qd059SdqcoonA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/sovos-brands-inc-nasdaq-sovo\/<\/a>.<\/p>\n<p>\n        <strong>Computer Task Group, Incorporated (Nasdaq &#8211; CTG)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, CTG will be acquired by Cegeka Groep nv (\u201cCegeka\u201d). CTG shareholders will receive $10.50 per share of common stock in an all-cash transaction, representing an implied equity value of approximately $170 million. The investigation concerns whether the CTG Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Cegeka paying less than full value for the Company.<\/p>\n<p align=\"justify\">Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RH8CixSm5isNw_-Z0yODtjTvNd17nuE8ECXLpsfTdY2HXddhanhNvRffAc7ZstmbW0t2AZVOX5RYLcjCEARucn4ufCMylMcwheRqYuIMoWRjaucjr3FqVA6iM0QHO0RgnxUQpcljS3xVte2OUYKCKU_3RHp1xLTk-cZwu3ZjBYGDGIfRvzuH_sCVZp1dSU2rGjab0OBZ3X4bmHTprOPUagku34DfZtVzGtq0b8DWPSHJmcDOT-K5Q7s4Lg8MjKCw\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/computer-task-group-incorporated-nasdaq-ctg\/<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, Decibel will be acquired by Regeneron Pharmaceuticals, Inc. (Nasdaq &#8211; REGN). Decibel shareholders will receive $4.00 per share of Decibel common stock payable in cash at closing, with an additional non-tradeable contingent value right (CVR) to receive up to $3.50 per share in cash upon achievement of certain clinical development and regulatory milestones for Decibel\u2019s lead investigational candidate, DB-OTO, within specified time periods. The proposed acquisition values Decibel at a total equity value of approximately $109 million based on the amount payable at closing, and a total equity value of up to approximately $213 million if the CVR milestones are achieved. The investigation concerns whether the Decibel Board breached its fiduciary duties to shareholders by failing to conduct a fair process resulting in Regeneron paying less than full value for the Company.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RH8CixSm5isNw_-Z0yODtjTvNd17nuE8ECXLpsfTdY2z8-O87XXtz8ws0pB__WfUNZgTMpI9vlOlLlOlsYbyRcjmUVT3XL55ZZgTAHMWna5NwO2CRb-WcigngAEYoX1BG2Cls0J_l99-LdtJTEF_45QaseNfhCozmq-RnYm60unUxNuNlyEgSaLWb_V5PUdVKNFlpuNb8Q0chCA2_M-QbRFk__WOUbyA9onht4f9yIc=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/decibel-therapeutics-inc-nasdaq-dbtx\/<\/a>.<\/p>\n<p align=\"justify\">Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YWVmYTFlYTYtODllMi00YTkxLWIyZWItNDVlMWQ3MzdkODNhLTExOTk4MzE=\/tiny\/Brodsky-Smith-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BALA CYNWYD, Pa., Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Acer Therapeutics Inc. (Nasdaq &#8211; ACER) Under the terms of the Agreement, Acer will be acquired by Zevra Therapeutics, Inc. (\u201cZevra\u201d) (Nasdaq &#8211; ZVRA). At closing, Zevra would issue 0.121 of a share of Zevra\u2019s common stock in respect of each share of Acer\u2019s common stock. In addition, Acer stockholders of record as of immediately prior to the effective time of the merger would receive non-transferable CVRs entitling the holders to receive up &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781374","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Acer Therapeutics Inc. (Nasdaq &#8211; ACER) Under the terms of the Agreement, Acer will be acquired by Zevra Therapeutics, Inc. (\u201cZevra\u201d) (Nasdaq &#8211; ZVRA). At closing, Zevra would issue 0.121 of a share of Zevra\u2019s common stock in respect of each share of Acer\u2019s common stock. In addition, Acer stockholders of record as of immediately prior to the effective time of the merger would receive non-transferable CVRs entitling the holders to receive up &hellip; Continue reading &quot;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-31T14:20:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)\",\"datePublished\":\"2023-08-31T14:20:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/\"},\"wordCount\":634,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/\",\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=\",\"datePublished\":\"2023-08-31T14:20:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Acer Therapeutics Inc. (Nasdaq &#8211; ACER) Under the terms of the Agreement, Acer will be acquired by Zevra Therapeutics, Inc. (\u201cZevra\u201d) (Nasdaq &#8211; ZVRA). At closing, Zevra would issue 0.121 of a share of Zevra\u2019s common stock in respect of each share of Acer\u2019s common stock. In addition, Acer stockholders of record as of immediately prior to the effective time of the merger would receive non-transferable CVRs entitling the holders to receive up &hellip; Continue reading \"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-31T14:20:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)","datePublished":"2023-08-31T14:20:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/"},"wordCount":634,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/","name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq - DBTX) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=","datePublished":"2023-08-31T14:20:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxNDUwNiM1NzkyODI1IzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-acer-therapeutics-inc-nasdaq-acer-sovos-brands-inc-nasdaq-sovo-computer-task-group-incorporat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq &#8211; ACER), Sovos Brands, Inc. (Nasdaq &#8211; SOVO), Computer Task Group, Incorporated (Nasdaq &#8211; CTG), Decibel Therapeutics, Inc. (Nasdaq &#8211; DBTX)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781374"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781374\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}